ANDA 208058, held by Heritage Pharma Avet. Lurasidone Hydrochloride.
As of Nov 16, 2026, ANDA 208058 (Lurasidone Hydrochloride), held by Heritage Pharma Avet, was first approved by FDA on Sep 4, 2019, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 4, 2019 | Original application | Approved |
| Lurasidone Hydrochloride20MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride40MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride60MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride80MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| Lurasidone Hydrochloride120MG · tablet;oral | Lurasidone Hydrochloride | Rx |
| May 14, 2026 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 25, 2021 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 4, 2019 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters